Tirzepatide, a novel medication, is sparking significant interest in the scientific community as a viable treatment for both type 2 diabetes and weight loss . This dual-action drug works by stimulating two different receptors, GLP-1 and GIP, leading to enhanced glycemic management and notable fat loss in testing. While early results are encouraging